Cefom-S 1.5g Injection

Cefoperazone 1000 mg + Sulbactam 500 mg Injection — IV Third-Gen Cephalosporin + BLI

Cefom-S 1.5g Injection — Cefoperazone 1000 mg + Sulbactam 500 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Cefoperazone 1000 mg + Sulbactam 500 mg
Dosage Form Injection (IV/IM)
Pack Type Vial
Pack Size 1 Vial of 1.5 g
MRP ₹ 345
Therapy Injectable + Antibiotic — Third-Gen Cephalosporin + Beta-Lactamase Inhibitor
Storage Store below 25 °C in a dry place, protected from light. Use within 24 hours after reconstitution.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Cefom-S 1.5g Injection

Cefom-S 1.5g Injection contains Cefoperazone 1000 mg with Sulbactam 500 mg, the standard 2:1 ratio injectable combination widely used in Indian hospital practice for serious gram-negative infections — particularly those caused by Pseudomonas aeruginosa, Acinetobacter and beta-lactamase-producing Enterobacteriaceae.

Cefoperazone is one of the few third-generation cephalosporins with intrinsic anti-pseudomonal activity. Sulbactam adds beta-lactamase inhibition plus its own intrinsic activity against Acinetobacter — making this combination particularly valuable in hospital-acquired infections, ICU-related sepsis and complicated intra-abdominal infections.

Cefom-S 1.5g is manufactured by Trumac Healthcare under WHO-GMP injectable conditions. Available for monopoly-based PCD pharma franchise, government tenders and third-party manufacturing — a hospital staple SKU.

Indications

  • Hospital-acquired infections including pneumonia
  • Septicaemia and bacteraemia
  • Complicated intra-abdominal and pelvic infections
  • Complicated UTI
  • Skin and soft-tissue infections caused by gram-negative or mixed flora
  • Surgical prophylaxis (high-risk procedures)

Mechanism of Action

Cefoperazone is a third-generation cephalosporin with strong gram-negative coverage including Pseudomonas aeruginosa. It binds penicillin-binding proteins to inhibit bacterial cell wall synthesis. Sulbactam (or tazobactam in combinations) is a beta-lactamase inhibitor that extends the spectrum to beta-lactamase-producing strains.

Dosage & Administration

Adults: 1.5–3 g every 12 hours by IV infusion or IM injection. Severe infections: up to 12 g/day in divided doses. Adjust dose in hepatic/renal impairment. Strictly hospital use.

Side Effects

Injection site pain, phlebitis, diarrhoea, mild rash. Disulfiram-like reaction with alcohol (Cefoperazone N-methylthiotetrazole side chain). Rare: hypoprothrombinaemia, hypersensitivity, pseudomembranous colitis.

Contraindications & Precautions

Hypersensitivity to cephalosporins. Severe penicillin allergy. Concurrent alcohol use. Severe hepatic impairment (cefoperazone is biliary-excreted).

Storage

Store below 25 °C in a dry place, protected from light. Use within 24 hours after reconstitution.

PCD Pharma Franchise & Third-Party Manufacturing
Cefom-S 1.5g Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Cefom-S 1.5g used for?

Cefom-S 1.5g contains Cefoperazone 1000 mg + Sulbactam 500 mg and is used for bacterial infections — UTI, ENT, respiratory tract, skin/soft-tissue infections in the appropriate age group.

How long is the course?

Typical course is 5–10 days; longer in complicated infections. Always complete the prescribed course.

Is Cefom-S 1.5g available for PCD pharma franchise?

Yes, Trumac Healthcare offers Cefom-S 1.5g on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Cefom-S 1.5g be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Cefom-S 1.5g WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.